• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Longer-term results back Rhythm’s ultrarare obesity drug fiercebiotech
    May 16, 2018
    Rhythm Pharma has additional data for its first-in-class obesity therapy setmelanotide—published in the prestigious journal Nature Medicine—showing that the drug’s effects can extend for over a year.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service